# Increasing seated reaction forces with lower body negative pressure

**Authors:** Suhas Rao Velichala, Jonathan Kim, Alan R. Hargens

PMC · DOI: 10.1038/s41526-025-00512-w · 2025-08-14

## TL;DR

This study shows that applying lower body negative pressure while seated increases reaction forces safely, which could help simulate Earth-like posture in space.

## Contribution

The study introduces seated LBNP as a safe method to simulate Earth-like seated posture in microgravity environments.

## Key findings

- Reaction forces increased significantly with rising LBNP levels, doubling by 30 mmHg.
- Cardiovascular parameters remained stable, indicating no acute hemodynamic risk.
- Force generation was dependent on LBNP amplitude and waist cross-sectional area.

## Abstract

This study evaluates reaction forces and cardiovascular responses during seated lower body negative pressure (LBNP). Ten healthy subjects were exposed to randomized LBNP levels (−10 to −40 mmHg) while seated in a sealed chamber. Gluteal, foot, and total reaction forces, along with heart rate and blood pressure, were measured at each level. Reaction forces increased significantly with rising LBNP (P < 0.05), exceeding baseline at 10 mmHg and doubling by 30 mmHg. Cardiovascular parameters remained stable, indicating no acute hemodynamic risk. Force generation was dependent on LBNP amplitude and waist cross-sectional area. These findings suggest that seated LBNP is a safe and effective method to simulate Earth-like seated posture in microgravity, offering a promising countermeasure to mitigate musculoskeletal deconditioning and support gravitational adaptation during long-duration spaceflight.

## Full-text entities

- **Genes:** GHRH (growth hormone releasing hormone) [NCBI Gene 2691] {aka GHRF, GRF, INN}
- **Diseases:** muscle atrophy (MESH:D009133), presyncope (MESH:D013575), LBNP (MESH:D064726), pain (MESH:D010146), bone density loss (MESH:D001851), neurological decrements (MESH:D009461), injuries (MESH:D014947), venous congestion (MESH:D006940), stroke (MESH:D020521), musculoskeletal atrophy (MESH:D009140), venous (MESH:D014647), bone loss (MESH:D001847), orthostatic intolerance (MESH:D054971), SANS (MESH:C000722495), deep vein thrombosis (MESH:D020246), vision impairment (MESH:D014786), thrombosis (MESH:D013927)
- **Chemicals:** caffeine (MESH:D002110), alcohol (MESH:D000438)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12350665/full.md

---
Source: https://tomesphere.com/paper/PMC12350665